Profitability:
Net income and net operating income increased in 2024 and 2025, with stronger per‑share earnings and higher underwriting margins alongside raised 2026 EPS guidance. Capital returns via dividends and ongoing share repurchases reinforce per‑share value creation.
Resilient & Sustainable Growth:
Revenue, total premium, and book value per share have risen over multiple years, with recent quarters showing continued premium gains across life and health. Guidance and division‑level momentum indicate continued steady top‑line growth with earnings expansion.
Market Expansion:
Multiple divisions report higher net sales and growing producing agent counts, while management is scaling middle‑management and offices with an explicit 2030 agent target. Digital initiatives and improving direct‑to‑consumer traction in late 2025 support broader reach.
